Results 71 to 80 of about 53,162 (283)
HBsAg TAŞIYICILARINDA VE HBsAg(-) KiŞiLERDE HDAg SERO PREVALANSI
European Journal of Therapeutics, 1993 Serum samples of 120 HBsAg ( +) asymptomatic carries and 120 sera from blood donors and health care personnel having neither HBsAg nor Anti-HBs were tested for the presence of HDAg. in the first group, 19 of the carries were HDAg positive (% 15.83). In the other group 2 health care personnel were HDAg positive (% 1.66).
İclal Balcı +2 more
openaire +1 more source
European Journal of Haematology, EarlyView.ABSTRACT BV + AVD is increasingly used for frontline treatment of stage III/IV cHL. Young adults and adults (Ya&A) were the most common patients treated with BV + AVD in clinical trials but have not been studied in non‐trial settings. We conducted a real‐life study in secondary and tertiary cancer centers to evaluate the PFS in 18–59 years aged ...
Marco Picardi +28 more
wiley +1 more source
HBsAg in Cord Blood Qf Newborns of HBsAg-Positive Mothers
Paediatrica Indonesiana, 2018 Vertical transmission of hepatitis B infection that may occur during pregnancy at delivery-, in infancy, and early childhood has an important role in the development of chronic hepatitis B. Intrauterine infection is suspected to occur when hepatitis B viruses cross the placenta into fetal circulation due to failure of placental tissue function.
Asri Rasad +4 more
openaire +2 more sources
HBsAg Quantification in Clinical Practice [PDF]
Journal of Clinical and Experimental Hepatology, 2012 Several standardized commercial assays for quantification of hepatitis B surface antigen (qHBsAg) are now available. Studies on HBsAg kinetics from Asia and Europe have demonstrated that HBsAg levels are highest during the immune-tolerant phase, become lower during immune-clearance phase and are the lowest in hepatitis B 'e' antigen (HBeAg)-negative ...
openaire +2 more sources
Hepatology Research, EarlyView.ABSTRACT Aims Understanding the molecular characteristics and genotype distribution of hepatitis B virus (HBV) is essential to elucidate intra and inter community transmission routes, identify cluster cases, and assess clinical implications based on genotype‐specific virulence.
Ko Ko +10 more
wiley +1 more source
HIV Medicine, EarlyView.Abstract Objectives Alterations in lipids and apolipoproteins contribute to cardiovascular disease (CVD) and are common in people with HIV. The aim of our study was to compare lipid profiles and body composition between people with and without HIV and to explore whether any associations with HIV could be explained by socio‐demographic, clinical ...
S. Savinelli +11 more
wiley +1 more source
Терапевтический архивAim. The objectives of the study: to conduct serologic screening for latent HBV infection in rheumatoid arthritis (RA) patients, to determine the level of protective antibodies to HBsAg in RA patients, and to determine the clinical and laboratory ...
Galina I. Gridneva +7 more
doaj +1 more source
Research in Pharmaceutical Sciences, 2016 Hepatitis B virus (HBV) is considered as a global health concern and hepatitis B surface antigen (HBsAg) is the most immunogenic protein of HBV. The purpose of this study was to evaluate the expression of HBsAg on the cell surface of human embryonic ...
Mina Mirian +6 more
doaj +1 more source
Major revision version 13.0 of the European AIDS Clinical Society guidelines 2025
HIV Medicine, EarlyView.Abstract Background The European AIDS Clinical Society (EACS) guidelines were revised for the 21st time in 2025, with updates covering all aspects of HIV care. Key Points of the Guidelines Update The structure of the guidelines has been reorganized into two parts: Part I focuses on the management and prevention of HIV and related infections, and Part ...
Juan Ambrosioni +19 more
wiley +1 more source